Background: Langerhans cells (LCs) polarize the immune milieu towards a T helper type (Th) 1 or Th2 immune response. We investigated the effects of selected tetracyclines on Th cells development mediated by LCs, and their implications for the treatment of atopic dermatitis (AD). Methods: Mice were primed with ovalbumin (OVA) peptide-pulsed LCs, which had been treated with each antibiotic, via the hind footpad. After 5 days, the Th1/Th2 cytokine response in the popliteal lymph nodes was investigated by enzyme-linked immunosorbent assay. The expression of cell surface molecules on LCs was investigated using reverse transcriptase polymerase chain reaction. The therapeutic effects of a selected antibiotic on AD-like skin lesions of NC/Nga mice were assessed in terms of the skin severity score, histological changes in the lesioned skin, the serum level of total IgE, and expression of Th1/Th2 cytokines in lymph nodes and skin lesions. Results: Antibiotic-treated, OVA peptide-pulsed LCs inhibited development of Th2 cells but not Th1 cells. This was accompanied by suppression of T-cell immunoglobulin and mucin domain-containing protein (TIM)-4 expression in LCs. Doxycycline had the greatest activity against Staphylococcus aureus strains isolated from skin lesions of patients with AD, and a strong inhibitory effect on Th2 cell development. Doxycycline suppressed the increase in the skin severity score during the acute phase in NC/Nga mice similar to betamethasone. This suppressive effect was associated with a decrease in the serum IgE level and production of Th2 cytokines in auricular lymph node cells and skin lesions. Conclusion: Topical application of doxycycline to AD lesions would act on both superficial S. aureus colonization and epidermal LCs, thus possibly inhibiting the development of Th2 cells in vivo, with benefits for control of acute inflammation in AD.
.Endogenous fragments of extracellular matrix are known to possess various biological
effects. Levels of endostatin, a fragment of collagen type XVIII, increase in certain
cardiac diseases, such as cardiac hypertrophy and myocardial infarction. However, the
influence of endostatin on cardiac contraction has not been clarified. In the present
study, we investigated the effects of endostatin on bradykinin-induced atrial contraction.
Isometric contractile force of mouse isolated left atria induced by electrical current
pulse was measured. Voltage-dependent calcium current of guinea pig ventricular myocytes
was measured by a whole-cell patch-clamp technique. Endostatin (100–1,000
ng/ml) alone treatment had no influence on left atrial
contraction. On the other hand, pretreatment with endostatin (300
ng/ml) significantly inhibited bradykinin (1
µM)-induced contraction and voltage-dependent calcium current. These
data suggest that endostatin may decrease bradykinin-induced cardiac contraction perhaps
through the inhibition of voltage-dependent calcium channel.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.